BCRP overexpresses in many cancer cell lines and can efflux a variety of chemotherapeutic agents including adriamycin, epirubicin, mitoxantrone, topotecan, methotrexate, doxorubicin, and flavopiridol out of the cell (9–11). The gene discussed is ABCG2; the disease is cancer.